IAEA Resource Listings
2023
A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer
Delgado Bolton, R.C., Calapaquí Terán, A.K., Gómez Román, J.J., Treglia, G., Giammarile, F., A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer [published online ahead of print, 2023 Mar 24],?Eur J Nucl Med Mol Imaging?(2023) 10.1007/s00259-023-06213-4. doi:10.1007/s00259-023-06213-4.
2023
Is there more than meets the eye than sentinel node localisation during lymphoscintigraphy mapping? Potential immunologic and therapeutic implications
Delgado Bolton, R.C., Calapaquí Terán, A.K., Treglia, G. et al. Is there more than meets the eye than sentinel node localisation during lymphoscintigraphy mapping? Potential immunologic and therapeutic implications. Eur J Nucl Med Mol Imaging 50, 635–637 (2023).
2022
Sentinel lymph node methods in breast cancer
GIAMMARILE, F. et al., Sentinel Lymph Node Methods in Breast Cancer, Seminars in Nuclear Medicine, Vol. 52, Elsevier BV (2022) pp. 551–560.
2022
Sentinel node biopsy imaging in breast cancer: Scatter reduction using 3D printed lead shields
CA–ETE-SáNCHEZ, F.M. et al., Sentinel Node Biopsy Imaging in Breast Cancer, Clinical Nuclear Medicine, Vol. 47, Ovid Technologies (Wolters Kluwer Health) (2022) pp. 618–624
2022
Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine
MIKHAIL LETTE, M.N. et al., Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine, JCO Global Oncology, American Society of Clinical Oncology (ASCO) (2022)
2022
Radioguided Surgery for Malignant Melanoma
VIDAL-SICART, S., ORSINI, F., GIAMMARILE, F., MARIANI, G., VALDéS OLMOS, R.A., Radioguided Surgery for Malignant Melanoma, Nuclear Oncology, Springer International Publishing (2022) pp. 1–38
2022
Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre.
HERRMANN, K. et al., Joint EANM, SNMMI and IAEA Enabling Guide: How to Set up a Theranostics Centre, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Springer Science and Business Media LLC (2022) pp. 2300–2309
2022
VALIDATION OF CONVOLUTIONAL NEURAL NETWORK FOR FAST DETERMINATION OF WHOLE-BODY METABOLIC TUMOR BURDEN IN PEDIATRIC LYMPHOMA
ETCHEBEHERE, E. et al., VALIDATION OF CONVOLUTIONAL NEURAL NETWORK FOR FAST DETERMINATION OF WHOLE-BODY METABOLIC TUMOR BURDEN IN PEDIATRIC LYMPHOMA, Journal of Nuclear Medicine Technology, Society of Nuclear Medicine (2022) p. jnmt.121.262900
2022
New Biomarkers With Prognostic Impact Based on Multitracer PET/CT Imaging in Neuroendocrine Neoplasms: The Light Leading Out of the Darkness in Challenging Tumors
DELGADO BOLTON, R.C., CALAPAQUí TERáN, A.K., FANTI, S., GIAMMARILE, F., New Biomarkers With Prognostic Impact Based on Multitracer PET/CT Imaging in Neuroendocrine Neoplasms, Clinical Nuclear Medicine, Vol. 47, Ovid Technologies (Wolters Kluwer Health) (2022) pp. 219–220
2021
The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions
BOLTON, R.C.D., TERáN, A.K.C., PELLET, O., FERRERO, A., GIAMMARILE, F., The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions, Clin Nucl Med 46 11 (2021) 906-907.
2021
Comparison [68Ga]FAP?-46 PET/CT and [131I] SPECT/CT findings after ablation therapy with high-activity 131-I therapy of metastatic papillary thyroid cancer patients: Two case reports
NOVRUZOV, F., et al., Comparison [68Ga]FAP?-46 PET/CT and [131I] SPECT/CT findings after ablation therapy with high-activity 131-I therapy of metastatic papillary thyroid cancer patients: Two case reports, (2021)
2021
Diagnostic performance and clinical impact of (68)Ga-PSMA-11 imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA study)
CERCI, J.J., et al., Diagnostic performance and clinical impact of (68)Ga-PSMA-11 imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA study), J Nucl Med (2021)
2021
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [(177)Lu]Lu-PSMA-617: a WARMTH multicentre study
AHMADZADEHFAR, H., et al., The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [(177)Lu]Lu-PSMA-617: a WARMTH multicentre study, Eur J Nucl Med Mol Imaging 48 12 (2021) 4067-4076.
2021
EANM guideline on the role of 2-[(18)F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the ACNM, SNMMI and IAEA
DELGADO BOLTON, R.C., et al., EANM guideline on the role of 2-[(18)F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA), Eur J Nucl Med Mol Imaging (2021)
2021
Neuroblastomas Current Diagnostic and Therapeutic Approaches in Nuclear Endocrinology
SHULKIN, B.L., et al., Neuroblastomas Current Diagnostic and Therapeutic Approaches in Nuclear Endocrinology, Cambridge Scholars Publishing: Current Diagnostic and Therapeutic Approaches in Nuclear Endocrinology, (2021).
2021
Comments to “Survey by the ANSM of the imaging protocol, detection rate and safety of 68Ga-PSMA-11 PET/CT“
GIAMMARILE, F., FANTI, S., Comments to “Survey by the ANSM of the imaging protocol, detection rate and safety of 68Ga-PSMA-11 PET/CT“, Eur J Nucl Med Mol I (2021) \
2021
Impact of (18)F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC
AL-IBRAHEEM, A., et al., Impact of (18)F-FDG PET/CT, CT and EBUS/TBNA on preoperative mediastinal nodal staging of NSCLC, BMC Med Imaging 21 1 (2021) 49.
2021
Medical imaging and nuclear medicine: a Lancet Oncology Commission
HRICAK, H., et al., Medical imaging and nuclear medicine: a Lancet Oncology Commission, The Lancet Oncology (2021)
2021
Pain Palliation of Bone Metastases: Production, Quality control and Dosimetry of Radiopharmaceuticals
KUDO, T., et al., Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study, JACC ASIA 1 2 (2021) 187-199.
2020
WHO framework for strengthening and scaling-up services for the management of invasive cervical cancer
BRAY, F., et al., WHO framework for strengthening and scaling-up services for the management of invasive cervical cancer, World Health Organization, (2020)